Affinity Asset Advisors, LLC
103 holdingsFiling period: 2026-03-31Current AUM: $2.27Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SPY | STATE STR SPDR S&P 500 ETF T | 200.0K | $130.1M | $149.4M | 6.58% | -- | 2026-03-31 |
| 2 | APGE | APOGEE THERAPEUTICS INC | 1.28M | $108.2M | $172.3M | 7.59% | +50.0K | 2026-03-31 |
| 3 | XENE | XENON PHARMACEUTICALS INC | 1.68M | $97.4M | $105.0M | 4.62% | +425.0K | 2026-03-31 |
| 4 | ERAS | ERASCA INC | 5.35M | $86.6M | $97.1M | 4.28% | +1.45M | 2026-03-31 |
| 5 | INSM | INSMED INC | 480.0K | $78.5M | $47.3M | 2.08% | +30.0K | 2026-03-31 |
| 6 | — | ROIVANT SCIENCES LTD | 2.80M | $77.6M | $77.6M | 3.42% | +1.10M | 2026-03-31 |
| 7 | SYRE | SPYRE THERAPEUTICS INC | 1.28M | $64.5M | $125.8M | 5.54% | -153,457 | 2026-03-31 |
| 8 | CNTA | CENTESSA PHARMACEUTICALS PLC | 1.40M | $55.6M | $55.6M | 2.45% | +799.4K | 2026-03-31 |
| 9 | PRAX | PRAXIS PRECISION MEDICINES I | 170.0K | $54.8M | $52.3M | 2.31% | -15,000 | 2026-03-31 |
| 10 | ANAB | ANAPTYSBIO INC | 940.0K | $52.1M | $50.2M | 2.21% | +495.3K | 2026-03-31 |
| 11 | — | ALKERMES PLC | 1.35M | $47.7M | $47.7M | 2.10% | +350.0K | 2026-03-31 |
| 12 | CYTK | CYTOKINETICS INC | 700.5K | $46.2M | $54.0M | 2.38% | -99,517 | 2026-03-31 |
| 13 | ABVX | ABIVAX SA | 405.0K | $45.1M | $50.6M | 2.23% | -100,000 | 2026-03-31 |
| 14 | TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.40M | $42.2M | $49.0M | 2.16% | -- | 2026-03-31 |
| 15 | ACLXGBX | ARCELLX INC | 362.8K | $41.7M | $41.7M | 1.83% | -160,961 | 2026-03-31 |
| 16 | MRNA | MODERNA INC | 800.0K | $40.6M | $43.9M | 1.93% | -- | 2026-03-31 |
| 17 | DNTH | DIANTHUS THERAPEUTICS INC | 400.0K | $33.6M | $42.8M | 1.88% | +285.0K | 2026-03-31 |
| 18 | NUVL | NUVALENT INC | 300.0K | $30.7M | $30.7M | 1.35% | -22,633 | 2026-03-31 |
| 19 | TERN | TERNS PHARMACEUTICALS INC | 562.6K | $29.7M | $29.7M | 1.31% | +12.6K | 2026-03-31 |
| 20 | LXEO | LEXEO THERAPEUTICS INC | 5.05M | $29.0M | $20.9M | 0.92% | +1.85M | 2026-03-31 |
| 21 | COGT | COGENT BIOSCIENCES INC | 750.0K | $28.9M | $29.2M | 1.29% | +400.0K | 2026-03-31 |
| 22 | MDGL | MADRIGAL PHARMACEUTICALS INC | 55.0K | $28.8M | $25.7M | 1.13% | +23.9K | 2026-03-31 |
| 23 | STRO | SUTRO BIOPHARMA INC | 1.07M | $26.6M | $25.8M | 1.14% | +321.1K | 2026-03-31 |
| 24 | FBRX | FORTE BIOSCIENCES INC | 1.01M | $26.2M | $77.5M | 3.41% | -- | 2026-03-31 |
| 25 | ORKA | ORUKA THERAPEUTICS INC | 499.7K | $24.5M | $48.2M | 2.12% | -302,669 | 2026-03-31 |
← Scroll →
Page 1 of 5